Rosuvastatin Tablet, Coated
Product Images NDC 11788-130

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 11788-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aiping Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg-1000 Tablets (10 mg 1000 Tablets)

10 mg-1000 Tablets (10 mg 1000 Tablets)
Label for Rosuvastatin Tablets USP 10 mg by AiPing Pharmaceutical, Inc. The label indicates a prescription drug with 1000 coated tablets in the package. It includes storage instructions, dosage referencing the package insert, and a barcode. The NDC is 11788-131-10.*
FDA Label Image

10 mg-500 Tablets (10 mg 500 Tablets)

10 mg-500 Tablets (10 mg 500 Tablets)
Label for Rosuvastatin Tablets, USP 10 mg by AiPing Pharmaceutical, Inc. The label indicates 500 coated oral tablets, with storage instructions and a barcode. It includes dosage information and patient safety warnings, with a website URL for additional patient information.*
FDA Label Image

10 mg-90 Tablets (10 mg 90 Tablets)

10 mg-90 Tablets (10 mg 90 Tablets)
Label for Rosuvastatin Tablets USP 10 mg, coated oral tablets, containing 90 tablets per container. The product is manufactured by AiPing Pharmaceutical, Inc., Hauppauge, NY. The label includes dosage instructions, storage conditions, and a barcode.*
FDA Label Image

20 mg-1000 Tablets (20 mg 1000 Tablets)

20 mg-1000 Tablets (20 mg 1000 Tablets)
The label for Rosuvastatin Tablets, USP 20 mg, oral coated tablets. The label shows the product is manufactured for AiPing Pharmaceutical, Inc., with a quantity of 1000 tablets. The label includes storage instructions, a barcode, and highlights that the tablets require a prescription (Rx Only).*
FDA Label Image

20 mg-500 Tablets (20 mg 500 Tablets)

20 mg-500 Tablets (20 mg 500 Tablets)
Label for Rosuvastatin Tablets, USP 20 mg coated tablets by AiPing Pharmaceutical, Inc. The label indicates a package of 500 tablets and includes storage instructions, dosage advisory, and a barcode. The product is prescription-only and the label shows the National Drug Code (NDC) 11788-132-05.*
FDA Label Image

20 mg-90 Tablets (20 mg 90 Tablets)

20 mg-90 Tablets (20 mg 90 Tablets)
Label for Rosuvastatin Tablets, USP 20 mg, coated oral tablets by AiPing Pharmaceutical, Inc. The label states a package size of 90 tablets and includes dosage, storage instructions, a barcode, and manufacturer information.*
FDA Label Image

40 mg-1000 Tablets (40 mg 1000 Tablets)

40 mg-1000 Tablets (40 mg 1000 Tablets)
Rosuvastatin Tablets USP 40 mg coated oral tablets label displaying the brand and generic name, strength, and package size of 1000 tablets. The label includes the NDC number 11788-133-10 and states Rx only. Manufactured for AiPing Pharmaceutical, Inc., Hauppauge, NY. Storage and handling instructions are provided, along with a barcode.*
FDA Label Image

40 mg-500 Tablets (40 mg 500 Tablets)

40 mg-500 Tablets (40 mg 500 Tablets)
This drug facts label panel for Rosuvastatin Tablets, USP 40 mg provides information on the active ingredient amount per tablet, storage conditions, packaging instructions, and safety warnings. It also includes the manufacturer AiPing Pharmaceutical, Inc., a website for patient information, and a barcode.*
FDA Label Image

40 mg-90 Tablets (40 mg 90 Tablets)

40 mg-90 Tablets (40 mg 90 Tablets)
Label for Rosuvastatin Tablets, USP 40 mg, coated oral tablets. The package contains 90 tablets and is labeled for prescription use only. Manufactured by AiPing Pharmaceutical, Inc., Hauppauge, NY. The label includes storage instructions and a barcode.*
FDA Label Image

5 mg-1000 Tablets (5 mg 1000 Tablets)

5 mg-1000 Tablets (5 mg 1000 Tablets)
Rosuvastatin Tablets, USP 5 mg coated oral tablets label from AiPing Pharmaceutical, Inc. The label indicates a package containing 1000 tablets. It includes storage instructions, dosage information to see package insert, a barcode, and a patient information website.*
FDA Label Image

5 mg-500 Tablets (5 mg 500 Tablets)

5 mg-500 Tablets (5 mg 500 Tablets)
Rosuvastatin Tablets USP 5 mg coated tablets packaging label. The label indicates the product is manufactured by AiPing Pharmaceutical, Inc. and contains 500 tablets. It provides dosage information, storage instructions, and a barcode. The label emphasizes prescription-only use and includes safety warnings about keeping the drug out of children’s reach.*
FDA Label Image

5 mg-90 Tablets (5 mg 90 Tablets)

5 mg-90 Tablets (5 mg 90 Tablets)
Label for Rosuvastatin Tablets, USP 5 mg, coated oral tablets supplied by AiPing Pharmaceutical, Inc. The package contains 90 tablets. The label includes storage instructions, dosage strength, NDC 11788-130-90, and directions to print patient information online.*
FDA Label Image

Rosuvastatin-figure1 (Rosuvastatin Figure1)

Rosuvastatin-figure1 (Rosuvastatin Figure1)
A line graph titled 'Time to First Occurrence of Major CV Events in JUPITER' showing cumulative incidence percentage over years. Two lines represent placebo (dashed) and Rosuva (solid) groups, with Rosuva showing lower cumulative incidence. A hazard ratio (HR) of 0.56 with 95% confidence interval and p-value is noted. The number at risk for RSV and Placebo groups is listed below the x-axis.*
FDA Label Image

Rosuvastatin-figure2 (Rosuvastatin Figure2)

Rosuvastatin-figure2 (Rosuvastatin Figure2)
A forest plot chart titled 'Major CV Events by Treatment Group in JUPITER' comparing Rosuvastatin 20 mg to Placebo 20 mg. It presents the number of events, hazard ratios with 95% confidence intervals, and p-values for cardiovascular outcomes including cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization.*
FDA Label Image

Rosuvastatin-figure3 (Rosuvastatin Figure3)

Rosuvastatin-figure3 (Rosuvastatin Figure3)
Box plot chart showing percent LDL-C change from baseline at week 6 by dose for Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin in adult patients with hyperlipidemia or mixed dyslipidemia. The x-axis shows doses in mg for each statin, and the y-axis shows percent change ranging from 0 to -75%. Results illustrate LDL-C reduction varying by statin type and dose.*
FDA Label Image

Structural Formula (Structuralformula Rosuvastatin)

Structural Formula (Structuralformula Rosuvastatin)
Chemical structure of rosuvastatin calcium, illustrating the detailed molecular arrangement including fluorophenyl, sulfonamide, hydroxy, and carboxylate groups with calcium ion coordination.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.